Screening of colorectal cancer: present and future

Marcello Maida, Fabio Salvatore Macaluso, Gianluca Ianiro, Francesca Mangiola, Emanuele Sinagra, Georgina Hold, Carlo Maida, Giovanni Cammarota, Antonio Gasbarrini, Giuseppe Scarpulla

Research output: Contribution to journalReview article

18 Citations (Scopus)

Abstract

INTRODUCTION: Colorectal cancer (CRC) is the third most common cancer in males and second in females, and the fourth most common cause of cancer death worldwide. Currently, about 60-70% of diagnosed cases in symptomatic patients are detected at an advanced stage of disease. Earlier stage detection through the use of screening strategies would allow for better outcomes in terms of reducing the disease burden. Areas covered: The aim of this paper is to review the current published evidence from literature which assesses the performance and effectiveness of different screening tests for the early detection of CRC. Expert commentary: Adequate screening strategies can reduce CRC incidence and mortality. In the last few decades, several tests have been proposed for CRC screening. To date, there is still insufficient evidence to identify which approach is definitively superior, and no screening strategy for CRC can therefore be defined as universally ideal. The best strategy would be the one that can be economically viable and to which the patient can adhere best to over time. The latest guidelines suggest colonoscopy every 10 years or annual fecal immuno-chemical test (FIT) for people with normal risk, while for individuals with high risk or hereditary syndromes specific recommendations are provided.

Original languageEnglish
Pages (from-to)1131-1146
Number of pages16
JournalExpert Review of Anticancer Therapy
Volume17
Issue number12
Early online date26 Oct 2017
DOIs
Publication statusPublished - 2017

Fingerprint

Colorectal Neoplasms
Early Detection of Cancer
Colonoscopy
Cause of Death
Neoplasms
Guidelines
Mortality
Incidence

Keywords

  • Journal Article
  • colorectal cancer
  • screening
  • surveillance
  • colonscopy
  • gFOBT
  • FIT

Cite this

Maida, M., Macaluso, F. S., Ianiro, G., Mangiola, F., Sinagra, E., Hold, G., ... Scarpulla, G. (2017). Screening of colorectal cancer: present and future. Expert Review of Anticancer Therapy, 17(12), 1131-1146. https://doi.org/10.1080/14737140.2017.1392243

Screening of colorectal cancer : present and future. / Maida, Marcello; Macaluso, Fabio Salvatore; Ianiro, Gianluca; Mangiola, Francesca; Sinagra, Emanuele; Hold, Georgina; Maida, Carlo; Cammarota, Giovanni; Gasbarrini, Antonio; Scarpulla, Giuseppe.

In: Expert Review of Anticancer Therapy, Vol. 17, No. 12, 2017, p. 1131-1146.

Research output: Contribution to journalReview article

Maida, M, Macaluso, FS, Ianiro, G, Mangiola, F, Sinagra, E, Hold, G, Maida, C, Cammarota, G, Gasbarrini, A & Scarpulla, G 2017, 'Screening of colorectal cancer: present and future', Expert Review of Anticancer Therapy, vol. 17, no. 12, pp. 1131-1146. https://doi.org/10.1080/14737140.2017.1392243
Maida M, Macaluso FS, Ianiro G, Mangiola F, Sinagra E, Hold G et al. Screening of colorectal cancer: present and future. Expert Review of Anticancer Therapy. 2017;17(12):1131-1146. https://doi.org/10.1080/14737140.2017.1392243
Maida, Marcello ; Macaluso, Fabio Salvatore ; Ianiro, Gianluca ; Mangiola, Francesca ; Sinagra, Emanuele ; Hold, Georgina ; Maida, Carlo ; Cammarota, Giovanni ; Gasbarrini, Antonio ; Scarpulla, Giuseppe. / Screening of colorectal cancer : present and future. In: Expert Review of Anticancer Therapy. 2017 ; Vol. 17, No. 12. pp. 1131-1146.
@article{3ef2ef833dd7420198281c484216a96c,
title = "Screening of colorectal cancer: present and future",
abstract = "INTRODUCTION: Colorectal cancer (CRC) is the third most common cancer in males and second in females, and the fourth most common cause of cancer death worldwide. Currently, about 60-70{\%} of diagnosed cases in symptomatic patients are detected at an advanced stage of disease. Earlier stage detection through the use of screening strategies would allow for better outcomes in terms of reducing the disease burden. Areas covered: The aim of this paper is to review the current published evidence from literature which assesses the performance and effectiveness of different screening tests for the early detection of CRC. Expert commentary: Adequate screening strategies can reduce CRC incidence and mortality. In the last few decades, several tests have been proposed for CRC screening. To date, there is still insufficient evidence to identify which approach is definitively superior, and no screening strategy for CRC can therefore be defined as universally ideal. The best strategy would be the one that can be economically viable and to which the patient can adhere best to over time. The latest guidelines suggest colonoscopy every 10 years or annual fecal immuno-chemical test (FIT) for people with normal risk, while for individuals with high risk or hereditary syndromes specific recommendations are provided.",
keywords = "Journal Article, colorectal cancer, screening, surveillance, colonscopy, gFOBT, FIT",
author = "Marcello Maida and Macaluso, {Fabio Salvatore} and Gianluca Ianiro and Francesca Mangiola and Emanuele Sinagra and Georgina Hold and Carlo Maida and Giovanni Cammarota and Antonio Gasbarrini and Giuseppe Scarpulla",
year = "2017",
doi = "10.1080/14737140.2017.1392243",
language = "English",
volume = "17",
pages = "1131--1146",
journal = "Expert Review of Anticancer Therapy",
issn = "1473-7140",
publisher = "Expert Reviews Ltd.",
number = "12",

}

TY - JOUR

T1 - Screening of colorectal cancer

T2 - present and future

AU - Maida, Marcello

AU - Macaluso, Fabio Salvatore

AU - Ianiro, Gianluca

AU - Mangiola, Francesca

AU - Sinagra, Emanuele

AU - Hold, Georgina

AU - Maida, Carlo

AU - Cammarota, Giovanni

AU - Gasbarrini, Antonio

AU - Scarpulla, Giuseppe

PY - 2017

Y1 - 2017

N2 - INTRODUCTION: Colorectal cancer (CRC) is the third most common cancer in males and second in females, and the fourth most common cause of cancer death worldwide. Currently, about 60-70% of diagnosed cases in symptomatic patients are detected at an advanced stage of disease. Earlier stage detection through the use of screening strategies would allow for better outcomes in terms of reducing the disease burden. Areas covered: The aim of this paper is to review the current published evidence from literature which assesses the performance and effectiveness of different screening tests for the early detection of CRC. Expert commentary: Adequate screening strategies can reduce CRC incidence and mortality. In the last few decades, several tests have been proposed for CRC screening. To date, there is still insufficient evidence to identify which approach is definitively superior, and no screening strategy for CRC can therefore be defined as universally ideal. The best strategy would be the one that can be economically viable and to which the patient can adhere best to over time. The latest guidelines suggest colonoscopy every 10 years or annual fecal immuno-chemical test (FIT) for people with normal risk, while for individuals with high risk or hereditary syndromes specific recommendations are provided.

AB - INTRODUCTION: Colorectal cancer (CRC) is the third most common cancer in males and second in females, and the fourth most common cause of cancer death worldwide. Currently, about 60-70% of diagnosed cases in symptomatic patients are detected at an advanced stage of disease. Earlier stage detection through the use of screening strategies would allow for better outcomes in terms of reducing the disease burden. Areas covered: The aim of this paper is to review the current published evidence from literature which assesses the performance and effectiveness of different screening tests for the early detection of CRC. Expert commentary: Adequate screening strategies can reduce CRC incidence and mortality. In the last few decades, several tests have been proposed for CRC screening. To date, there is still insufficient evidence to identify which approach is definitively superior, and no screening strategy for CRC can therefore be defined as universally ideal. The best strategy would be the one that can be economically viable and to which the patient can adhere best to over time. The latest guidelines suggest colonoscopy every 10 years or annual fecal immuno-chemical test (FIT) for people with normal risk, while for individuals with high risk or hereditary syndromes specific recommendations are provided.

KW - Journal Article

KW - colorectal cancer

KW - screening

KW - surveillance

KW - colonscopy

KW - gFOBT

KW - FIT

U2 - 10.1080/14737140.2017.1392243

DO - 10.1080/14737140.2017.1392243

M3 - Review article

C2 - 29022408

VL - 17

SP - 1131

EP - 1146

JO - Expert Review of Anticancer Therapy

JF - Expert Review of Anticancer Therapy

SN - 1473-7140

IS - 12

ER -